Enzymes and General Principles of Metabolism: Catalysis, Kinetics, Inhibition, Regulation, Coenzymes and ATP
2. Michaelis–Menten kinetics
For E + S ⇌ ES → E + P, with rate constants k₁, k₋₁ and k₂ (= kcat), the steady-state assumption ([ES] constant while [S] ≫ [E]) gives the Michaelis–Menten equation v₀ = Vmax[S]/(Km + [S]), where Km = (k₋₁ + k₂)/k₁ and Vmax = kcat[E]T. Km is the substrate concentration at which v₀ = Vmax/2; it equals the dissociation constant of ES only when k₂ ≪ k₋₁. At [S] ≪ Km the rate is first order in S, v₀ ≈ (kcat/Km)[E]T[S]; at [S] ≫ Km it is zero order. Useful fractions: [S] = Km gives 50% of Vmax, 4Km gives 80% and 9Km gives 90%.
- kcat, the turnover number, is the number of substrate molecules converted per active site per second when the enzyme is saturated.
- kcat/Km, the specificity constant, is the second-order rate constant for E + S at low [S]. It ranks competing substrates and is capped by diffusion at about 10⁸–10⁹ M⁻¹ s⁻¹, which triose phosphate isomerase and acetylcholinesterase approach.
- Lineweaver–Burk (double-reciprocal) plot: 1/v₀ = (Km/Vmax)(1/[S]) + 1/Vmax, so the y-intercept is 1/Vmax, the x-intercept −1/Km and the slope Km/Vmax. It overweights the low-[S] points, which carry the largest errors; the Eadie–Hofstee plot (v₀ against v₀/[S], slope −Km) spreads the data more evenly.
3. Kinetics with two substrates
Most enzymes have two substrates (A + B ⇌ P + Q). In sequential mechanisms both substrates bind before any product leaves, forming a ternary complex EAB; binding may be ordered (lactate dehydrogenase binds NADH before pyruvate) or random. In the ping-pong (double-displacement) mechanism the first substrate hands a group to the enzyme and the first product leaves before the second substrate binds, through a substituted enzyme E*. Aminotransferases shuttle the amino group through enzyme-bound pyridoxal phosphate and pyridoxamine phosphate; chymotrypsin's acyl-enzyme follows the same logic.
The mechanisms are told apart by measuring v₀ against [A] at several fixed [B] and plotting 1/v₀ against 1/[A]. Sequential mechanisms give lines that intersect to the left of the 1/v₀ axis, because [B] changes both slope and intercept; ping-pong gives parallel lines, because [B] changes only the intercept. Product inhibition patterns then separate ordered from random binding, and isotope exchange between A and P in the absence of B reveals the substituted enzyme of a ping-pong mechanism.
4. Enzyme inhibitors
A reversible inhibitor binds non-covalently and is characterised by an inhibition constant. Define α = 1 + [I]/Ki for binding to free E and α′ = 1 + [I]/Ki′ for binding to ES.
| Type | Binds | Apparent Vmax | Apparent Km | Lineweaver–Burk lines |
|---|---|---|---|---|
| Competitive | Free E, at the active site | Unchanged | αKm | Meet on the 1/v₀ axis |
| Uncompetitive | ES only | Vmax/α′ | Km/α′ | Parallel |
| Mixed | E and ES, Ki ≠ Ki′ | Vmax/α′ | αKm/α′ | Meet left of the 1/v₀ axis, off the 1/[S] axis |
| Pure noncompetitive | E and ES equally | Vmax/α | Unchanged | Meet on the 1/[S] axis |
Competitive inhibition is overcome by raising [S]; uncompetitive inhibition is not, and grows stronger as [S] rises. Example: 15 µM of a competitive inhibitor raises the apparent Km from 2.0 to 8.0 mM, so α = 4 and Ki = 15/3 = 5 µM. Irreversible inhibitors bond covalently or bind so tightly that dialysis does not remove them, so they reduce the amount of active enzyme: group-specific reagents (diisopropyl fluorophosphate on an active-site Ser, iodoacetamide on Cys), affinity labels (TPCK on His57 of chymotrypsin) and mechanism-based (suicide) inactivators, which the target enzyme itself converts into a reactive form. Many drugs are inhibitors: statins compete with HMG-CoA at HMG-CoA reductase; methotrexate binds dihydrofolate reductase extremely tightly as a folate analogue; aspirin acetylates a Ser of cyclooxygenase; penicillin acylates the transpeptidase that cross-links peptidoglycan; and allopurinol is converted by xanthine oxidase into oxypurinol, which stays bound.
5. Regulation and regulatory enzymes
Pathways are controlled at a few committed, usually irreversible steps by regulatory enzymes. Allosteric enzymes have separate regulatory sites, are usually multi-subunit, and give sigmoidal curves of v₀ against [S], described by K0.5 instead of Km; activators shift the curve left and inhibitors right. The classic case is aspartate transcarbamoylase (ATCase) of E. coli, which commits aspartate to pyrimidine synthesis. It has six catalytic and six regulatory chains; CTP, the end product, inhibits it (feedback inhibition) and ATP activates it, balancing purine and pyrimidine supply. Catalytic trimers separated from the regulatory chains stay active but give hyperbolic kinetics and ignore CTP and ATP. Phosphofructokinase-1 is likewise inhibited by ATP and citrate and activated by AMP and fructose 2,6-bisphosphate.
- Reversible covalent modification, mostly phosphorylation by kinases and its reversal by phosphatases, acts in seconds to minutes: phosphorylation activates glycogen phosphorylase and inactivates glycogen synthase and pyruvate dehydrogenase.
- Proteolytic activation of zymogens (trypsinogen, chymotrypsinogen, clotting factors) switches an enzyme on once and irreversibly.
- Isozymes suit kinetics to tissues. Hexokinase I has a Km far below blood glucose and is inhibited by glucose 6-phosphate; glucokinase of liver and pancreatic β-cells is half-saturated only at several millimolar glucose and is not inhibited by glucose 6-phosphate, so it responds to the rise in blood glucose after a meal.
- Enzyme amount, set by induction, repression and degradation, is the slow control acting over hours.
6. Vitamins and coenzymes
Many enzymes need a non-protein cofactor, either a metal ion or an organic coenzyme; one bound tightly or covalently is a prosthetic group (heme, the FAD of succinate dehydrogenase, biotin). Apoenzyme plus cofactor gives the active holoenzyme. Most water-soluble vitamins are coenzyme precursors, so a deficiency shows up as failure of the reactions that need the coenzyme. Of the fat-soluble vitamins only K acts as a coenzyme; A gives the 11-cis-retinal of rhodopsin, D gives the hormone calcitriol, and E is a membrane antioxidant.
| Vitamin | Coenzyme form | Reaction (example) | Deficiency |
|---|---|---|---|
| B1 thiamine | Thiamine pyrophosphate | Oxidative decarboxylation of α-keto acids (pyruvate dehydrogenase); transketolase | Beriberi; Wernicke–Korsakoff syndrome in alcoholism |
| B2 riboflavin | FMN, FAD | Redox (succinate and acyl-CoA dehydrogenases) | Cheilosis, glossitis |
| B3 niacin | NAD⁺, NADP⁺ | Hydride transfer by dehydrogenases | Pellagra (dermatitis, diarrhoea, dementia) |
| B5 pantothenate | Coenzyme A, acyl carrier protein | Acyl transfer as thioesters | Rare |
| B6 pyridoxine | Pyridoxal phosphate | Transamination, amino acid decarboxylation; glycogen phosphorylase | Neuropathy, for example during isoniazid therapy |
| B7 biotin | Enzyme-bound biotin | ATP-dependent carboxylation (pyruvate carboxylase, acetyl-CoA carboxylase) | Rare; avidin of raw egg white binds it |
| B9 folate | Tetrahydrofolate | One-carbon transfer (purines, thymidylate) | Megaloblastic anaemia; neural tube defects |
| B12 cobalamin | Methylcobalamin, 5′-deoxyadenosylcobalamin | Methionine synthase; methylmalonyl-CoA mutase | Megaloblastic anaemia with nerve damage (pernicious anaemia) |
| C ascorbate | Ascorbate itself, as reductant | Prolyl and lysyl hydroxylases of collagen | Scurvy |
| K | Reduced vitamin K | γ-Carboxylation of Glu in clotting factors II, VII, IX, X | Bleeding; warfarin blocks its recycling |
7. General principles of metabolism and its hormonal regulation
Catabolism breaks fuels down, converging on a few intermediates (pyruvate, acetyl-CoA, citric acid cycle intermediates) and conserving energy as ATP and reducing power as NADH and FADH₂; anabolism diverges from these intermediates to build macromolecules, spending ATP and NADPH. Four principles recur. Opposing pathways are never simple reversals: at least one step uses a different, irreversible reaction (phosphofructokinase-1 in glycolysis against fructose 1,6-bisphosphatase in gluconeogenesis), so each direction is favourable, can be regulated on its own, and futile cycling is avoided. Control acts at far-from-equilibrium steps, with large negative ΔG and a mass-action ratio far below K′eq, while near-equilibrium steps simply follow the flux. NADH serves catabolism and NADPH biosynthesis. Compartments separate opposing pathways, such as fatty acid synthesis in the cytosol and β-oxidation in mitochondria.
| Hormone | Signal and receptor | Main metabolic effects |
|---|---|---|
| Insulin | High blood glucose; receptor tyrosine kinase on liver, muscle, adipose tissue | GLUT4 moves to the membrane in muscle and fat; glycogen, fat and protein synthesis rise; gluconeogenesis and lipolysis fall |
| Glucagon | Low blood glucose; mainly liver, through Gs, cAMP and protein kinase A | Glycogen breakdown and gluconeogenesis rise; fructose 2,6-bisphosphate falls, slowing glycolysis |
| Epinephrine | Stress and exercise; β-adrenergic receptors and cAMP in muscle, liver, fat | Glycogen breakdown; glycolysis in muscle; lipolysis in fat |
| Cortisol | Prolonged stress or fasting; intracellular (nuclear) receptor | Induces gluconeogenic enzymes; muscle protein breakdown supplies amino acids |
In type 1 diabetes, missing insulin leaves glucagon unopposed: the liver keeps releasing glucose, adipose tissue releases fatty acids, and the liver turns the excess acetyl-CoA into ketone bodies, causing ketoacidosis.
8. Generation and utilisation of ATP
Hydrolysis of ATP to ADP + Pi has ΔG°′ ≈ −30.5 kJ mol⁻¹. Four effects make it large: relief of repulsion between the negatively charged phosphates, resonance stabilisation of free Pi, ionisation of ADP (releasing H⁺ at pH 7) and better solvation of the products. The real substrate of most enzymes is Mg²⁺·ATP. Cells hold [ATP] far above equilibrium, so the actual ΔG = ΔG°′ + RT ln([ADP][Pi]/[ATP]) is about −50 to −65 kJ mol⁻¹. Example at 310 K with ATP 4.0, ADP 0.40 and Pi 2.0 mM: the ratio is 2.0 × 10⁻⁴, ln = −8.52, RT = 2.577 kJ mol⁻¹, so ΔG = −30.5 − 21.95 ≈ −52 kJ mol⁻¹.
| Compound | ΔG°′ | Role |
|---|---|---|
| Phosphoenolpyruvate | −61.9 | Makes ATP via pyruvate kinase |
| 1,3-Bisphosphoglycerate | −49.3 | Makes ATP via phosphoglycerate kinase |
| Phosphocreatine | −43.0 | ATP buffer in muscle (creatine kinase) |
| ATP → ADP + Pi | −30.5 | Intermediate carrier |
| Glucose 6-phosphate | −13.8 | Made from ATP by hexokinase |
| Glycerol 3-phosphate | −9.2 | Made from ATP by glycerol kinase |
Compounds above ATP can phosphorylate ADP and ATP can phosphorylate those below it, so ATP is the intermediate carrier of phosphoryl groups. ATP is generated by substrate-level phosphorylation (phosphoglycerate kinase and pyruvate kinase in glycolysis, succinyl-CoA synthetase in the citric acid cycle), by oxidative phosphorylation, in which ATP synthase is driven by the proton-motive force of the respiratory chain, and by photophosphorylation. It is used by coupling: group transfer makes unfavourable steps favourable (glucose + Pi → glucose 6-phosphate, +13.8 kJ mol⁻¹, becomes −16.7 kJ mol⁻¹ when coupled to ATP); it drives transport (Na⁺/K⁺-ATPase), movement (myosin) and polymer synthesis, where cleavage to AMP + PPi and hydrolysis of PPi by pyrophosphatase make the step effectively irreversible.
Key takeaways
- Enzymes lower ΔG‡ by binding the transition state more tightly than the substrate; they do not change ΔG°′ or K′eq. Acid–base, covalent, metal-ion and proximity effects add to binding energy, and induced fit and multi-point binding give specificity.
- v₀ = Vmax[S]/(Km + [S]); Km = (k₋₁ + kcat)/k₁ is the [S] giving Vmax/2; kcat = Vmax/[E]T; kcat/Km measures efficiency, capped by diffusion near 10⁸–10⁹ M⁻¹ s⁻¹. In the Lineweaver–Burk plot the y-intercept is 1/Vmax, the x-intercept −1/Km and the slope Km/Vmax.
- Sequential two-substrate mechanisms form a ternary complex and give intersecting double-reciprocal lines; ping-pong mechanisms pass through a substituted enzyme and give parallel lines.
- Competitive inhibitors raise Km (α = 1 + [I]/Ki), uncompetitive ones lower Vmax and Km together, pure noncompetitive ones lower Vmax only; irreversible and suicide inactivators survive dialysis. Statins, methotrexate, aspirin, penicillin and allopurinol are enzyme inhibitors.
- Flux is controlled at irreversible committed steps by allosteric enzymes (ATCase: CTP inhibits, ATP activates; PFK-1), phosphorylation, zymogen activation, isozymes and enzyme amount; insulin against glucagon, epinephrine and cortisol sets the fed–fasting switch. Water-soluble vitamins are coenzyme precursors, and each deficiency maps to the reactions that fail.
- ATP hydrolysis has ΔG°′ ≈ −30.5 kJ mol⁻¹ but about −50 to −65 kJ mol⁻¹ in cells, from ΔG = ΔG°′ + RT ln([ADP][Pi]/[ATP]). ATP's intermediate phosphoryl transfer potential makes it the carrier between high-energy donors (PEP, 1,3-BPG, phosphocreatine) and acceptors; AMP and the energy charge report the cell's energy state.
Practice questions (18)
Attempt each one before opening the answer. Every explanation names the tempting wrong option as well as the right one, because that is where marks are lost.
Which statement correctly describes the effect of an enzyme on the reaction it catalyses?
Show answer
Answer: C — It lowers ΔG‡, speeding the forward and reverse reactions equally without changing K′eq
A catalyst lowers the activation free energy by stabilising the transition state; because the same transition state lies on the forward and reverse paths, both rates rise by the same factor and K′eq (fixed by ΔG°′) is unchanged. An enzyme cannot change ΔG°′ or supply free energy; making an unfavourable reaction go requires coupling to a favourable one, such as ATP hydrolysis, which is a different matter from catalysis.An enzyme that uses pyridoxal phosphate catalyses L-glutamate + pyruvate ⇌ α-ketoglutarate + L-alanine. To which EC class does it belong?
Show answer
Answer: B — Transferases, because an amino group is moved from one molecule to another
This is an aminotransferase (transaminase), EC class 2: the amino group passes from glutamate to the enzyme's pyridoxal phosphate and then to pyruvate, with no external electron acceptor such as NAD⁺. The oxidoreductase answer is tempting because glutamate becomes a keto acid, but the electrons stay within the paired substrates. Ligases need ATP, and lyases do not transfer a group to a second substrate.Glycolysis and gluconeogenesis share most of their enzymes but use different enzymes at three steps. What is the main reason these three glycolytic steps are not simply run in reverse?
Show answer
Answer: D — Those steps have large negative ΔG in cells, so separate irreversible reactions are needed and allow separate control
Hexokinase, phosphofructokinase-1 and pyruvate kinase operate far from equilibrium with large negative ΔG, so their reverse is strongly unfavourable; gluconeogenesis bypasses them with different, also exergonic reactions (pyruvate carboxylase with PEP carboxykinase, fructose 1,6-bisphosphatase, glucose 6-phosphatase). Having distinct enzymes lets the two pathways be regulated reciprocally and avoids futile cycling. The bypass is not explained by NADPH, which gluconeogenesis does not use, nor by enzyme degradation.An enzyme obeys Michaelis–Menten kinetics. With the same enzyme concentration, the initial rate is 30 µmol min⁻¹ at [S] = 2.0 mM and 50 µmol min⁻¹ at [S] = 6.0 mM. What is Vmax, in µmol min⁻¹?
Numerical answer — type the value.
Show answer
Answer: 75
Vmax = v₀(Km + [S])/[S] must be the same at both points: 30(Km + 2)/2 = 50(Km + 6)/6, so 15Km + 30 = 8.333Km + 50, giving Km = 3.0 mM. Then Vmax = 15 × (3 + 2) = 75 µmol min⁻¹. Check: 75 × 6/9 = 50. Assuming the higher rate is already Vmax (50) is the usual slip.A Lineweaver–Burk plot (1/v₀ in min µM⁻¹ against 1/[S] in µM⁻¹) for an enzyme is a straight line with slope 0.040 min and y-intercept 0.0125 min µM⁻¹. What is Km in µM? Give the answer to one decimal place.
Numerical answer — type the value.
Show answer
Answer: 3.2
y-intercept = 1/Vmax, so Vmax = 1/0.0125 = 80 µM min⁻¹. Slope = Km/Vmax, so Km = 0.040 × 80 = 3.2 µM. Equivalently, the x-intercept is −0.0125/0.040 = −0.3125 µM⁻¹ = −1/Km, giving Km = 3.2 µM.A purified enzyme at a total active-site concentration of 10 nM gives Vmax = 5.0 µM s⁻¹ and Km = 25 µM. What is its specificity constant kcat/Km, expressed in units of 10⁶ M⁻¹ s⁻¹?
Numerical answer — type the value.
Show answer
Answer: 20
kcat = Vmax/[E]T = (5.0 × 10⁻⁶ M s⁻¹)/(10 × 10⁻⁹ M) = 500 s⁻¹. kcat/Km = 500/(25 × 10⁻⁶ M) = 2.0 × 10⁷ M⁻¹ s⁻¹ = 20 × 10⁶ M⁻¹ s⁻¹, about a tenth of the diffusion limit. Forgetting to convert µM and nM to M gives answers off by powers of ten.For an enzyme catalysing A + B → P + Q, initial rates are measured against [A] at several fixed concentrations of B. Which of the following statements are correct?
Show answer
Answer: A — In a ping-pong mechanism, plots of 1/v₀ against 1/[A] at the different fixed [B] are parallel lines; D — In a ping-pong mechanism the first product leaves before the second substrate binds, leaving a substituted enzyme
In ping-pong kinetics [B] changes only the intercept of the 1/v₀ against 1/[A] plot, so the lines are parallel, and the mechanism passes through a substituted enzyme after the first product leaves. Intersecting lines are the signature of sequential mechanisms, which do form a ternary complex, so that statement is reversed. Aminotransferases are the textbook ping-pong case, carrying the amino group as pyridoxamine phosphate.In the presence of a drug, the Lineweaver–Burk plot of an enzyme is a line parallel to the control line but shifted upward. What kind of inhibitor is the drug, and how does it change the kinetic constants?
Show answer
Answer: A — Uncompetitive; it binds only the ES complex and lowers apparent Vmax and Km by the same factor
An uncompetitive inhibitor divides both Vmax and Km by α′, so the slope Km/Vmax is unchanged and only the intercept 1/Vmax rises: parallel lines. Competitive inhibition changes the slope but not the y-intercept (lines meet on the 1/v₀ axis); pure noncompetitive inhibition changes the slope and y-intercept but not the x-intercept (lines meet on the 1/[S] axis); mixed inhibition gives lines that cross left of the 1/v₀ axis.At 8.0 µM, a competitive inhibitor raises the apparent Km of an enzyme from 1.5 mM to 4.5 mM and leaves Vmax unchanged. What is the Ki of the inhibitor, in µM?
Numerical answer — type the value.
Show answer
Answer: 4
For competitive inhibition, apparent Km = αKm with α = 1 + [I]/Ki. α = 4.5/1.5 = 3, so [I]/Ki = 2 and Ki = 8.0/2 = 4 µM. Taking Ki = [I]/α (2.7 µM) is the common slip.Compound Z lowers the Vmax of an enzyme and leaves its Km unchanged. Which single experiment would best show whether Z is a reversible pure noncompetitive inhibitor or an irreversible inactivator?
Show answer
Answer: B — Dialyse or gel-filter the enzyme–Z mixture and assay again; activity returns only if Z binds reversibly
Both kinds of inhibitor remove a fraction of the enzyme from action without changing the affinity of the rest, so both lower Vmax, leave Km unchanged, are not overcome by substrate and give lines meeting on the 1/[S] axis. Only removal of free Z separates them: a reversible inhibitor dissociates during dialysis or gel filtration and activity returns, whereas a covalently bound inactivator stays attached.Which of the following statements about drugs that act by inhibiting enzymes are correct?
Show answer
Answer: B — Aspirin irreversibly inactivates cyclooxygenase by acetylating a serine residue; C — Allopurinol is converted by xanthine oxidase into oxypurinol, which stays tightly bound and inactivates the enzyme
Aspirin transfers its acetyl group to a serine of cyclooxygenase, an irreversible covalent change, and allopurinol is a mechanism-based (suicide) inactivator because xanthine oxidase itself makes the tightly bound oxypurinol. Statins resemble HMG-CoA and compete with it at the active site; they are competitive, not uncompetitive. Methotrexate is a folate analogue that binds dihydrofolate reductase extremely tightly and non-covalently; thymidylate synthase is affected only indirectly, through loss of tetrahydrofolate.Aspartate transcarbamoylase of E. coli shows sigmoidal kinetics, is inhibited by CTP and is activated by ATP. If its catalytic trimers are separated from the regulatory chains and assayed alone, what is observed?
Show answer
Answer: C — Catalytic activity with hyperbolic kinetics that is no longer affected by either CTP or ATP
The active sites lie within the catalytic trimers (between adjacent catalytic chains), so isolated trimers are active. CTP and ATP bind the regulatory chains, so without them there is no feedback control, and the cooperative T⇌R transition of the whole c₆r₆ assembly is lost, giving hyperbolic kinetics. This experiment showed that allosteric and catalytic sites are on different subunits; the claim that CTP acts at the catalytic site is therefore wrong.In the liver of a fasting person, glucagon raises cAMP and activates protein kinase A. Which consequence helps switch the liver from glycolysis to gluconeogenesis?
Show answer
Answer: A — PKA phosphorylates the bifunctional PFK-2/FBPase-2, lowering fructose 2,6-bisphosphate
Phosphorylation of the liver bifunctional enzyme inhibits its kinase (PFK-2) and activates its phosphatase (FBPase-2), so fructose 2,6-bisphosphate falls. Since this compound activates PFK-1 and inhibits fructose 1,6-bisphosphatase, its fall slows glycolysis and speeds gluconeogenesis. Fructose 2,6-bisphosphate activates rather than inhibits PFK-1, so raising it would do the opposite; phosphorylation inactivates glycogen synthase; GLUT4 is an insulin-regulated transporter of muscle and fat, not liver.Which of the following vitamin – coenzyme – reaction pairings are correct?
Show answer
Answer: C — Biotin – enzyme-bound biotin – ATP-dependent carboxylation of pyruvate to oxaloacetate; D — Pyridoxine – pyridoxal phosphate – transamination of amino acids
Pyruvate carboxylase carries CO₂ on biotin, and aminotransferases use pyridoxal phosphate. One-carbon units for thymidylate are carried by tetrahydrofolate (from folate), not by thiamine pyrophosphate, which serves α-keto acid decarboxylation and transketolase. Prolyl hydroxylation in collagen needs ascorbate (vitamin C); vitamin K serves γ-carboxylation of glutamate in clotting factors.A man with chronic alcoholism presents with confusion, an unsteady gait and weakness of eye movements. His blood pyruvate and lactate are raised and his erythrocyte transketolase activity is low. Deficiency of which coenzyme best explains these findings?
Show answer
Answer: D — Thiamine pyrophosphate, which is needed by pyruvate dehydrogenase and transketolase
The picture is Wernicke's encephalopathy from thiamine deficiency, common in alcoholism. Without thiamine pyrophosphate, pyruvate dehydrogenase fails, so pyruvate accumulates and is reduced to lactate, and transketolase activity (the standard test of thiamine status) falls; the brain, which relies on glucose oxidation, is hit first. Pyridoxal phosphate deficiency would not lower transketolase or block pyruvate oxidation, and folate deficiency presents as megaloblastic anaemia.In a cell at 310 K, [ATP] = 3.0 mM, [ADP] = 0.30 mM and [Pi] = 3.0 mM. Take ΔG°′ for ATP + H₂O → ADP + Pi as −30.5 kJ mol⁻¹ and R = 8.314 J mol⁻¹ K⁻¹, and ignore activity coefficients and Mg²⁺ binding. What is the actual ΔG of ATP hydrolysis in this cell, in kJ mol⁻¹? Give the answer with its sign, to one decimal place.
Numerical answer — type the value.
Show answer
Answer: -51.4
Mass-action ratio = [ADP][Pi]/[ATP] = (0.30 × 10⁻³)(3.0 × 10⁻³)/(3.0 × 10⁻³) = 3.0 × 10⁻⁴ (concentrations in M); ln(3.0 × 10⁻⁴) = −8.112. RT = 8.314 × 310 = 2577 J mol⁻¹ = 2.577 kJ mol⁻¹. RT ln Q = −20.91 kJ mol⁻¹. ΔG = −30.5 − 20.91 = −51.4 kJ mol⁻¹. Writing the ratio upside down gives −9.6, a sign that the products and reactants were swapped.Standard free energies of hydrolysis (ΔG°′, kJ mol⁻¹) are: phosphoenolpyruvate −61.9, phosphocreatine −43.0, ATP to ADP + Pi −30.5, glucose 6-phosphate −13.8 and glycerol 3-phosphate −9.2. Which phosphoryl transfer is favourable under standard conditions?
Show answer
Answer: B — Phosphoenolpyruvate + ADP → pyruvate + ATP
For donor-P + ADP → donor + ATP, ΔG°′ = ΔG°′(donor hydrolysis) + 30.5. PEP: −61.9 + 30.5 = −31.4 kJ mol⁻¹, favourable (the pyruvate kinase step). Glucose 6-phosphate: +16.7; glycerol 3-phosphate: +21.3. Making phosphocreatine from ATP: −30.5 + 43.0 = +12.5 kJ mol⁻¹, unfavourable under standard conditions; it proceeds in resting muscle only because of the cellular concentrations.In working muscle, [ATP] falls by only about 10% while [AMP] rises several-fold, and AMP rather than ATP acts as the main signal that activates phosphofructokinase-1, glycogen phosphorylase b and AMP-activated protein kinase. Why is AMP the more sensitive signal?
Show answer
Answer: C — Adenylate kinase keeps 2 ADP ⇌ ATP + AMP near equilibrium, so with [ATP] ≫ [AMP] a small fall in ATP is a large rise in AMP
Adenylate kinase equilibrates the adenylates, so [AMP] ≈ K[ADP]²/[ATP]. When ATP is used, ADP rises and AMP rises roughly with the square of ADP; because AMP starts at a small concentration, its fractional change is many times that of ATP. This amplification makes AMP the alarm signal. Myosin produces ADP + Pi, not AMP; AMP's action is intracellular, not a blood-borne report; and AMP acts at its own allosteric sites rather than displacing ATP from every site.